Modulation of Amyloid and Tau Aggregation to Alleviate Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Modulation of Amyloid and Tau Aggregation to Alleviate Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease

Published:2024-06-26 Issue:9 Volume:7 Page:2650-2661
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Park Sohui¹,Shin Jisu¹,Kim Kyeonghwan¹^ORCID,Kim Darong²,Lee Won Seok²,Lee Jusuk²,Cho Illhwan¹,Park In Wook¹,Yoon Soljee¹³,Lee Songmin¹,Kim Hye Yun¹^ORCID,Lee Ji Hoon²,Hong Ki Bum²^ORCID,Kim YoungSoo¹³⁴^ORCID

Affiliation:

1. Department of Pharmacy and Yonsei Institute of Pharmaceutical Science, Yonsei University, Incheon 21983, Republic of Korea

2. New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (KMEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea

3. Department of Integrative Biotechnology and Translational Medicine, Yonsei University, Incheon 21983, Republic of Korea

4. Department of Psychiatry, Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea

Funder

Korea Health Industry Development Institute

Korea Dementia Research Center

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.4c00006

Reference50 articles.

1. Neuropathological Alterations in Alzheimer Disease

2. Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

3. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease

4. Amyloid-β and Tau

5. Role of tau protein in Alzheimer's disease: The prime pathological player